We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
-15.75%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$4.54B
AUM Growth
-$1.27B
Cap. Flow
-$395M
Cap. Flow %
-8.71%
Top 10 Hldgs %
42.65%
Holding
327
New
47
Increased
54
Reduced
101
Closed
69

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$151M
2
DGX icon
Quest Diagnostics
DGX
+$135M
3
VISN
Vistance Networks Inc
VISN
+$95.6M
4
TXT icon
Textron
TXT
+$81.1M
5
CVS icon
CVS Health
CVS
+$72M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$161M
2
NOK icon
Nokia
NOK
+$112M
3
PCG icon
PG&E
PCG
+$94.2M
4
GD icon
General Dynamics
GD
+$93.3M
5
PFE icon
Pfizer
PFE
+$88.2M

Sector Composition

Rank Sector Weight
1 Financials 19%
2 Healthcare 14.48%
3 Technology 13.44%
4 Consumer Discretionary 10.91%
5 Consumer Staples 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD icon
1
DuPont de Nemours
DD
$18.7B
$290M 6.39%
2,143,038
+446,731
+26% +$64.2M
GM icon
2
General Motors
GM
$80.9B
$199M 4.38%
5,950,637
-720,315
-11% -$24.9M
OXY icon
3
Occidental Petroleum
OXY
$55.7B
$196M 4.31%
3,189,506
-175,644
-5% -$12.3M
T icon
4
AT&T
T
$164B
$192M 4.23%
8,911,036
-1,271,947
-12% -$29.6M
PFE icon
5
Pfizer
PFE
$144B
$191M 4.2%
4,610,007
-2,124,476
-32% -$88.2M
C icon
6
Citigroup
C
$213B
$186M 4.1%
3,577,528
-365,170
-9% -$23.1M
INTC icon
7
Intel
INTC
$413B
$181M 3.99%
3,855,693
-1,866,351
-33% -$87.4M
AIG icon
8
American International
AIG
$42.5B
$170M 3.75%
4,321,643
-596,761
-12% -$26.1M
THS
9
DELISTED
Treehouse Foods
THS
$167M 3.68%
3,296,060
+51,943
+2% +$2.56M
ETN icon
10
Eaton
ETN
$141B
$164M 3.6%
2,383,486
+206,660
+9% +$15.5M
BIO icon
11
Bio-Rad Laboratories Class A
BIO
$8.75B
$132M 2.91%
569,205
+561,328
+7,126% +$151M
AAPL icon
12
Apple
AAPL
$4.96T
$127M 2.8%
3,227,520
+164,152
+5% +$7.96M
DGX icon
13
Quest Diagnostics
DGX
$26B
$120M 2.64%
+1,438,145
New +$135M
BAC icon
14
Bank of America
BAC
$429B
$118M 2.59%
4,768,880
-86,267
-2% -$2.34M
POST icon
15
Post Holdings
POST
$4.42B
$103M 2.28%
1,772,740
+113,761
+7% +$6.85M
JPM icon
16
JPMorgan Chase
JPM
$917B
$97.5M 2.15%
998,762
-20,472
-2% -$2.18M
NOK icon
17
Nokia
NOK
$46.9B
$88.1M 1.94%
15,132,930
-19,982,208
-57% -$112M
HES
18
DELISTED
Hess
HES
$87.6M 1.93%
2,161,907
+58,217
+3% +$3.32M
GT icon
19
Goodyear
GT
$2.09B
$87.5M 1.93%
4,287,158
-348,065
-8% -$7.54M
IP icon
20
International Paper
IP
$22.6B
$83.7M 1.84%
2,190,395
-292,953
-12% -$12.3M
LAB icon
21
Standard BioTools
LAB
$342M
$82.5M 1.82%
9,567,068
-634,723
-6% -$4.94M
VISN
22
Vistance Networks Inc
VISN
$2.6B
$73.9M 1.63%
+4,510,573
New +$95.6M
TXT icon
23
Textron
TXT
$14.9B
$66.4M 1.46%
+1,443,386
New +$81.1M
ATH
24
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$65.6M 1.45%
1,647,752
+99,294
+6% +$4.47M
LOW icon
25
Lowe's Companies
LOW
$121B
$64.6M 1.42%
699,455
+206,770
+42% +$19.9M
1
2 3 4 5

Similar funds

MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
MCM
Mill Capital Management Concord, North Carolina $1.31B AUM 17.4% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

Levin Capital Strategies's Q4 2018 Portfolio in Review

As of Q4 2018, Levin Capital Strategies held 327 positions worth $4.54B, down 22% from $5.81B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Levin Capital Strategies withdrew a net $395M in Q4 2018, closing 69 positions and reducing 101 holdings. Its most notable exit was General Dynamics, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Levin Capital Strategies opened a new position in Quest Diagnostics worth $120M.

  • Levin Capital Strategies's largest Q4 2018 buy was Quest Diagnostics: 1,438,145 shares worth $120M.
  • Levin Capital Strategies added most to Bio-Rad Laboratories Class A in Q4 2018, an estimated $151M increase.
  • Levin Capital Strategies's biggest Q4 2018 reduction was Merck, cutting an estimated $161M.
  • Levin Capital Strategies fully exited General Dynamics in Q4 2018, selling an estimated $93.3M.
  • Levin Capital Strategies's ten largest holdings make up 43% of its $4.54B portfolio in Q4 2018.
  • Levin Capital Strategies opened 47 new positions and closed 69 in Q4 2018.
  • Levin Capital Strategies's portfolio value fell 22% quarter-over-quarter to $4.54B.

Based on Levin Capital Strategies's 13F filing for Q4 2018, filed 5 Feb 2019.